Fluspirilene

This classification denotes an antipsychotic agent and dopamine antagonist with the molecular formula C29H31F2N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C5QA4GLR9M, chemically known as 1,3,8-triazaspiro(4.5)decan-4-one, 8-(4,4-bis(4-fluorophenyl)butyl)-1-phenyl- but generally known as fluspirilene, which bears US NIH Compound Identifier 3396. European Medicines Agency schedules Fluspirilene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07755MIG. World Health Organization schedules fluspirilene in its Anatomical Therapeutic Chemical (ATC) Classification. FLUSPIRILENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fluspirilene under HS 29333999 and SITC 51574. As of Q4 2014, FLUSPIRILENE remains the US FDA Preferred Term for this commodity. SMILES: FC1CCC(C(CCCN2CCC3(N(CNC3=O)C3CCCCC3)CC2)C2CCC(F)CC2)CC1.